These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37191924)

  • 41. Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.
    Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Tröbs M; Röther J; Schlundt C; Achenbach S; Hamm C; Nef H
    Heart Vessels; 2017 Jul; 32(7):781-789. PubMed ID: 28004176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes of bioresorbable vascular scaffold in ST-elevation myocardial infarction.
    de Hemptinne Q; Picard F; Ly HQ; Ibrahim R; Asgar AW; de Guise P; Doucet S; Dorval JF; Marquis-Gravel G; Levi M; L-L'allier P; Tanguay JF
    Acta Cardiol; 2018 Jun; 73(3):276-281. PubMed ID: 28954592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: Optical coherence tomography evaluation and clinical outcomes.
    Kochman J; Tomaniak M; Pietrasik A; Kołtowski Ł; Rdzanek A; Huczek Z; Mazurek T; Jąkała J; Ząbek A; Legutko J; Kochman W; Filipiak KJ
    Cardiol J; 2015; 22(3):315-22. PubMed ID: 25428734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early vascular responses to everolimus-eluting cobalt-chromium stent in the culprit lesions of st-elevation myocardial infarction: results from a multicenter prospective optical coherence tomography study (MECHANISM-AMI 2-week follow-up study).
    Morino Y; Terashita D; Otake H; Kikuchi T; Fusazaki T; Kuriyama N; Suzuki T; Ito Y; Hibi K; Tanaka H; Ishihara S; Kataoka T; Morita T; Otsuka Y; Hayashi T; Tanabe K; Shinke T
    Cardiovasc Interv Ther; 2019 Jan; 34(1):14-24. PubMed ID: 29318464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OCT-assessment of scaffold resorption: Analysis of strut intensity by a new resorption index for poly-l-lactic acid bioresorbable vascular scaffolds.
    Blachutzik F; Achenbach S; Marwan M; Tröbs M; Boeder N; Doerr O; Weissner M; Bauer T; Nef H; Hamm C; Schlundt C
    Catheter Cardiovasc Interv; 2019 Dec; 94(7):928-935. PubMed ID: 30945432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans.
    Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branches.
    Paradies V; Smits PC; Vachojannis GJ; Royaards KJ; Wassing J; van der Ent M
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):279-285. PubMed ID: 29066339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Gutiérrez-Barrios A; Gheorghe LL; Camacho Freire S; Silva E; Gómez Menchero A; Francisco Jose MP; Cañadas Pruaño D; Martínez Capoccioni U; Gomez Lara J; Bretones Del Pino T; Calle Perez G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):E69-E77. PubMed ID: 33600069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: a randomized controlled trial.
    Eriksen E; Neghabat O; Saeed S; Herstad J; Nordrehaug JE; Tuseth V; Holm NR; Holck EN; Sejr-Hansen M; Maule CF; Barkholt TØ; Andreasen LN; Christiansen EH; Bleie Ø
    Coron Artery Dis; 2023 Jan; 34(1):1-10. PubMed ID: 36484214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
    Räber L; Yamaji K; Kelbæk H; Engstrøm T; Baumbach A; Roffi M; von Birgelen C; Taniwaki M; Moschovitis A; Zaugg S; Ostojic M; Pedrazzini G; Karagiannis-Voules DA; Lüscher TF; Kornowski R; Tüller D; Vukcevic V; Heg D; Windecker S
    Eur Heart J; 2019 Jun; 40(24):1909-1919. PubMed ID: 30851032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'.
    Kočka V; Malý M; Toušek P; Buděšínský T; Lisa L; Prodanov P; Jarkovský J; Widimský P
    Eur Heart J; 2014 Mar; 35(12):787-94. PubMed ID: 24419808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune-inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective.
    Kozel M; Kočka V; Lisa L; Buděšínský T; Toušek P
    Heart Vessels; 2019 Apr; 34(4):557-563. PubMed ID: 30315494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optical Coherence Tomographic Image Pattern of Metallic Bioresorbable Vascular Scaffold Restenosis.
    Roa-Garrido J; Cardenal-Piris RM; El Amrawy AM; Gomez-Menchero A; Camacho Freire S; Diaz-Fernandez JF
    JACC Cardiovasc Interv; 2018 Apr; 11(7):707-708. PubMed ID: 29550091
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).
    Moscarella E; Ielasi A; Varricchio A; De Angelis MC; Loi B; Tarantini G; Calabrò P; Cortese B; Mazzarotto P; Gabrielli G; Pisano F; Facchin M; Misuraca L; Lucci V; Gistri R; Tumminello G; Moretti L; Colombo A; Durante A; Fineschi M; Piraino D; Ferrario M; Coscarelli S; Nicolino A; Tespili M; Corrado D; Steffenino G
    Int J Cardiol; 2018 May; 258():50-54. PubMed ID: 29429635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study.
    Widimsky P; Petr R; Tousek P; Maly M; Linkova H; Vrana J; Hajsl M; Budesinsky T; Lisa L; Kocka V
    Circ Cardiovasc Interv; 2015 Dec; 8(12):e002933. PubMed ID: 26628591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of optical coherence tomography findings on clinical outcomes in ST-segment elevation myocardial infarction patients: a MATRIX (Minimizing Adverse Hemorrhagic Events by Trans-radial Access Site and angioX) OCT sub-study.
    Yacob O; Garcia-Garcia HM; Dan K; Soud M; Adamo M; Picchi A; Sardella G; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabro P; Ando G; Varbella F; Garducci S; Palmieri C; Briguori C; Kuku KO; Karagiannis A; Valgimigli M
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1143-1150. PubMed ID: 33225426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-Segment Elevation Myocardial Infarction: Rationale, Design, and Methodology of the HONEST Study.
    Fallesen CO; Maehara A; Antonsen L; Nørregaard Hansen K; Noori M; Flensted Lassen J; Junker A; Hansen HS; Okkels Jensen L
    Cardiology; 2021; 146(2):161-171. PubMed ID: 33524985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.
    Ielasi A; Varricchio A; Campo G; Leoncini M; Cortese B; Vicinelli P; Brugaletta S; di Uccio FS; Latib A; Tespili M
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1129-1138. PubMed ID: 27774758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First Evidence of Complete Resorption 4 Years After Bioresorbable Scaffold Implantation in the Setting of ST-Segment Elevation Myocardial Infarction.
    Gori T; Münzel T
    JACC Cardiovasc Interv; 2017 Jan; 10(2):200-202. PubMed ID: 28040446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.